
MRI Radiomics to Predict Early Treatment Response to TACE Combined with Lenvatinib Plus a PD-1 Inhibitor for ...
Introduction Hepatocellular carcinoma (HCC), a significant global health challenge, ranks sixth among the most common cancers and is the third highest cause of cancer-related mortality. Globocan’s latest statistics report nearly 865,000 new cases and …